Meanwhile, current study focused on the tumor suppressor role of STAT5A in luminal and triple-negative subtypes of breast cancer, which is proposed as a novel biomarker for metastasis of breast cancer, evoking the potential therapeutic effect of analogs of STAT5A or N3ICD/STAT5A axis. Here, STAT5A is linked to breast carcinoma.